Resultados de la búsqueda 61-70 of 1342 for ������������������������������������:VB20��������������������� ������

1. Hematología - Ensayos clínicos - Mayo Clinic

   All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Probiotics Preventing Immune Checkpoint Inhibitor-Induced Colitis · To evaluate the safety of multi-strain probiotic blend in cancer patients receiving ICIs. · To ...

3. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

   The postnatal diagnosis of Long QT Syndrome (LQTS) is suggested by a prolonged QT interval on 12 lead electrocardiogram (ECG),a positive family history ...

4. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

   The Specific Aims of this study are: 1. To identify the genetic causes of bicuspid aortic valve disease and its associated thoracic aortic disease. 2. To ...

5. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

   Bicuspid aortic valve (BAV) disease is the most frequent congenital cardiac malformation, occurring in 0.5-1.2% of the US population.

6. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

   The Specific Aims of this study are: 1. To identify the genetic causes of bicuspid aortic valve disease and its associated thoracic aortic disease. 2. To ...

7. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

   Bicuspid aortic valve (BAV) disease is the most frequent congenital cardiac malformation, occurring in 0.5-1.2% of the US population.

8. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

   The Specific Aims of this study are: 1. To identify the genetic causes of bicuspid aortic valve disease and its associated thoracic aortic disease. 2. To ...

9. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

   Bicuspid aortic valve (BAV) disease is the most frequent congenital cardiac malformation, occurring in 0.5-1.2% of the US population.

10. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...